|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | Prescribing pattern of diabetic patients with and without chronic kidney disease: A cross sectional study in a tertiary care hospital in Mandya |
| Authors Name: | Diffy C John , Bhoomika K S , Athira E , Dr. A Vikneswari , Dr. Issac C Joy 6.Aarabi I U 7.Anusha V 8.Prakash N P |
| Unique Id: | IJSDR2311039 |
| Published In: | Volume 8 Issue 11, November-2023 |
| Abstract: | Diabetes mellitus (DM) is a metabolic syndrome which is characterized by elevated level of glucose in the blood due to body’s inability to produce or respond to insulin. Chronic kidney disease (CKD) describe as the gradual decrease in kidney function. The kidney filters waste and excess fluids from the blood that excreted in the form of urine. Diabetic is a common cause for CKD. People who are suffering from diabetes cause kidney damage by various factors, including changes in kidney due to diabetes. The main aim of our study is to upgrade patient knowledge about DM and CKD and also to describe the prescribing pattern involved in it. OBJECTIVE: To describe prescribing pattern of drugs for diabetes patients with CKD and also for DM patients without CKD. METHODOLOGY: A cross-sectional study on 230 diabetes patients with and without CKD was enrolled from the Department of general medicine, MIMS Mandya. RESULTS: Out 230 patients, 111 suffered from diabetes with CKD and 119 suffered from diabetes without CKD. The study shows that the majority of the patients were prescribed with OHA (57%) rather than insulin (43%) in diabetes patients without CKD and insulin (53%) rather than OHA (47%) in diabetes patients with CKD. In our study, among OHA Metformin (36.54%) was most commonly prescribed drug in diabetes patients without CKD and Metformin + Glimipiride ( 34.83%) was most commonly prescribed drug in diabetes patients with CKD. Among insulin, short acting insulin (HUMAN ACTRAPID) was most commonly prescribed for diabetic patients without CKD (69%) and diabetic patients with CKD (64%). CONCLUSION: The study shows that in diabetes patients, developing a CKD is more common than in non-diabetic patients. So we can make better patient quality of life by monitoring and controlling the blood sugar level in diabetes patients, which can reduce the risk of CKD. |
| Keywords: | DM, CKD, Oral Hypoglycaemic Agent (OHA), Insulin. |
| Cite Article: | "Prescribing pattern of diabetic patients with and without chronic kidney disease: A cross sectional study in a tertiary care hospital in Mandya ", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 11, page no.274 - 280, November-2023, Available :http://www.ijsdr.org/papers/IJSDR2311039.pdf |
| Downloads: | 000338719 |
| Publication Details: | Published Paper ID: IJSDR2311039 Registration ID:209268 Published In: Volume 8 Issue 11, November-2023 DOI (Digital Object Identifier): Page No: 274 - 280 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn